Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bussink

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Radiation Research|October 12, 2000
Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft linesJ Bussink, J H Kaanders, A M Strik, et al.
British Journal of Cancer|February 12, 1998
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenograftsJ Bussink, J H Kaanders, P F Rijken, et al.
Radiation Research|April 13, 2000
Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor lineJ Bussink, J H Kaanders, P F Rijken, et al.
British Journal of Cancer|July 17, 2003
Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcomeP N Span, J Bussink, P Manders, et al.
Medical Physics|May 19, 2017
SU-E-T-06: A Mathematical Explanation to Tumor's Response to Perfusion and Hypoxic Fraction after RadiationY Yan, M Kissick, J Bussink, et al.
Nuclear Medicine and Biology|November 23, 2024
The potential of targeted radionuclide therapy to treat hypoxic tumor cellsS T M Wenker, S A M van Lith, G Tamborino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Changes in tumor hypoxia measured with a double hypoxic marker techniqueA S Ljungkvist, J Bussink, P F Rijken, et al.
Plant Molecular Biology|December 5, 2013
Nodulin gene expression during soybean (Glycine max) nodule developmentT Gloudemans, S de Vries, H J Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 1999
Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamideJ Bussink, J H Kaanders, P F Rijken, et al.
Nuklearmedizin. Nuclear Medicine|January 29, 2014
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patientsB A W Hoeben, E G C Troost, J Bussink, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Radiation Research|October 12, 2000
Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft linesJ Bussink, J H Kaanders, A M Strik, et al.
British Journal of Cancer|February 12, 1998
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenograftsJ Bussink, J H Kaanders, P F Rijken, et al.
Radiation Research|April 13, 2000
Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor lineJ Bussink, J H Kaanders, P F Rijken, et al.
British Journal of Cancer|July 17, 2003
Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcomeP N Span, J Bussink, P Manders, et al.
Medical Physics|May 19, 2017
SU-E-T-06: A Mathematical Explanation to Tumor's Response to Perfusion and Hypoxic Fraction after RadiationY Yan, M Kissick, J Bussink, et al.
Nuclear Medicine and Biology|November 23, 2024
The potential of targeted radionuclide therapy to treat hypoxic tumor cellsS T M Wenker, S A M van Lith, G Tamborino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Changes in tumor hypoxia measured with a double hypoxic marker techniqueA S Ljungkvist, J Bussink, P F Rijken, et al.
Plant Molecular Biology|December 5, 2013
Nodulin gene expression during soybean (Glycine max) nodule developmentT Gloudemans, S de Vries, H J Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 1999
Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamideJ Bussink, J H Kaanders, P F Rijken, et al.
Nuklearmedizin. Nuclear Medicine|January 29, 2014
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patientsB A W Hoeben, E G C Troost, J Bussink, et al.
Pageof 5